Advertisement

Ads Placeholder
Loading...

Financière de Tubize SA

TUB.BREURONEXT
Healthcare
Biotechnology
219.50
1.50(0.69%)
U.S. Market opens in 55h 43m

Financière de Tubize SA Fundamental Analysis

Financière de Tubize SA (TUB.BR) shows weak financial fundamentals with a PE ratio of 104.80, profit margin of 0.00%, and ROE of 4.88%. The company generates N/A in annual revenue with weak year-over-year growth of -1.00%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE4.88%
Operating Margin0.00%
Cash Position0.01%
PEG Ratio219.04
Current Ratio0.03
We analyze TUB.BR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -75.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-75.1/100

We analyze TUB.BR's fundamental strength across five key dimensions:

Efficiency Score

Weak

TUB.BR struggles to generate sufficient returns from assets.

ROA > 10%
4.82%

Valuation Score

Weak

TUB.BR trades at a premium to fair value.

PE < 25
104.80
PEG Ratio < 2
219.04

Growth Score

Weak

TUB.BR faces weak or negative growth trends.

Revenue Growth > 5%
-1.00%
EPS Growth > 10%
3.47%

Financial Health Score

Moderate

TUB.BR shows balanced financial health with some risks.

Debt/Equity < 1
0.00
Current Ratio > 1
0.03

Profitability Score

Weak

TUB.BR struggles to sustain strong margins.

ROE > 15%
4.88%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is TUB.BR Expensive or Cheap?

P/E Ratio

TUB.BR trades at 104.80 times earnings. This suggests a premium valuation.

104.80

PEG Ratio

When adjusting for growth, TUB.BR's PEG of 219.04 indicates potential overvaluation.

219.04

Price to Book

The market values Financière de Tubize SA at 5.18 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.18

EV/EBITDA

Enterprise value stands at -3298.43 times EBITDA. This is generally considered low.

-3298.43

How Well Does TUB.BR Make Money?

Net Profit Margin

For every $100 in sales, Financière de Tubize SA keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $4.88 in profit for every $100 of shareholder equity.

4.88%

ROA

Financière de Tubize SA generates $4.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

4.82%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.09 in free cash annually.

$-0.09

FCF Yield

TUB.BR converts -0.04% of its market value into free cash.

-0.04%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

104.80

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

219.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.18

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.05

vs 25 benchmark

ROA

Return on assets percentage

0.05

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How TUB.BR Stacks Against Its Sector Peers

MetricTUB.BR ValueSector AveragePerformance
P/E Ratio104.8028.45 Worse (Expensive)
ROE4.88%763.00% Weak
Net Margin0.00%-45265.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio0.032795.60 Weak Liquidity
ROA4.82%-16588.00% (disorted) Weak

TUB.BR outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Financière de Tubize SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-64.21%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

13.19%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ